Major intravenous extravasation injuries.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003646:Debridement; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D006230:Hand Injuries / Q000139:chemically induced; D006801:Humans; D006982:Hypertonic Solutions / Q000009:adverse effects; D007049:Iatrogenic Disease; D007223:Infant; D007231:Infant, Newborn; D007263:Infusions, Parenteral / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology; D014662:Vasoconstrictor Agents / Q000009:adverse effects; D014947:Wounds and Injuries / Q000209:etiology*
D000970:Antineoplastic Agents; D006982:Hypertonic Solutions; D014662:Vasoconstrictor Agents; D004317:Doxorubicin